LEADER 04451nam 22012015 450 001 9910136160603321 005 20230803214716.0 035 $a(CKB)3780000000048953 035 $a(MH)014196219-4 035 $a(SSID)ssj0001568459 035 $a(PQKBManifestationID)16214590 035 $a(PQKBTitleCode)TC0001568459 035 $a(PQKBWorkID)14813302 035 $a(PQKB)11558929 035 $a(PPN)193420732 035 $a(EXLCZ)993780000000048953 100 $a20140513d2014 my b 101 0 $afre 181 $ctxt 182 $cc 183 $acr 200 10$aEthique, droit et maladie d'Alzheimer$b[electronic resource] 210 $aParis 210 $cAcademia 210 $d2014 215 $a1 online resource (88 p.) 225 0 $aIntellection âEthique, droit et maladie d'Alzheimer 300 $aAnne Meyer-Heine 330 $aL'ouvrage consiste à aborder les questions éthiques, juridiques et de gouvernance politique impliquées dans la prise en charge des patients atteints de la maladie d'Alzheimer. Cette politique multi niveaux (municipale, départementale, régionale, nationale et européenne) est un des champs d'action publique des plus innovants en matière de politique de santé et un espace d'expérimentation de nouveaux référentiels éthico politiques d'action et d'évaluation. 606 $aAlzheimer's disease$xMoral and ethical aspects 606 $aAlzheimer's disease$xLaw and legislation 606 $aAlzheimer's disease$xPatients$xCare 606 $aAlzheimer Disease 606 $aHealth Policy 606 $aEthics, Medical 606 $aPublic Policy 606 $aTauopathies 606 $aDementia 606 $aEthics, Clinical 606 $aNeurodegenerative Diseases 606 $aDelirium, Dementia, Amnestic, Cognitive Disorders 606 $aSocial Control Policies 606 $aEthics, Professional 606 $aBrain Diseases 606 $aPolicy 606 $aMental Disorders 606 $aNervous System Diseases 606 $aCentral Nervous System Diseases 606 $aEthics 606 $aSocial Control, Formal 606 $aPsychiatry and Psychology 606 $aDiseases 606 $aHumanities 606 $aHealth Care Quality, Access, and Evaluation 606 $aHealth Care Economics and Organizations 606 $aSociology 606 $aSocial Sciences 606 $aAnthropology, Education, Sociology and Social Phenomena 606 $aHealth Care 606 $aPsychiatric Disorders, Individual$2HILCC 606 $aPsychiatry$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 0$aAlzheimer's disease$xMoral and ethical aspects 615 0$aAlzheimer's disease$xLaw and legislation 615 0$aAlzheimer's disease$xPatients$xCare 615 2$aAlzheimer Disease 615 2$aHealth Policy 615 2$aEthics, Medical 615 2$aPublic Policy 615 2$aTauopathies 615 2$aDementia 615 2$aEthics, Clinical 615 2$aNeurodegenerative Diseases 615 2$aDelirium, Dementia, Amnestic, Cognitive Disorders 615 2$aSocial Control Policies 615 2$aEthics, Professional 615 2$aBrain Diseases 615 2$aPolicy 615 2$aMental Disorders 615 2$aNervous System Diseases 615 2$aCentral Nervous System Diseases 615 2$aEthics 615 2$aSocial Control, Formal 615 2$aPsychiatry and Psychology 615 2$aDiseases 615 2$aHumanities 615 2$aHealth Care Quality, Access, and Evaluation 615 2$aHealth Care Economics and Organizations 615 2$aSociology 615 2$aSocial Sciences 615 2$aAnthropology, Education, Sociology and Social Phenomena 615 2$aHealth Care 615 7$aPsychiatric Disorders, Individual 615 7$aPsychiatry 615 7$aHealth & Biological Sciences 700 $aAnne Meyer-Heine$0852740 702 $aMeyer-Heine$b Anne 702 $aMeyer-Heine$b Anne 906 $aBOOK 912 $a9910136160603321 996 $aEthique, droit et maladie d'Alzheimer$91904294 997 $aUNINA 999 $aThis Record contains information from the Harvard Library Bibliographic Dataset, which is provided by the Harvard Library under its Bibliographic Dataset Use Terms and includes data made available by, among others the Library of Congress